Retrospective evaluation of a decision‐support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors

Neuroblastoma is the most common pediatric extracranial solid tumor. Germline pathogenic variants in ALK and PHOX2B, as well as other cancer predisposition genes, are increasingly implicated in the pathogenesis of neuroblastic tumors. A challenge for clinicians is the identification of children with neuroblastoma who require genetics evaluation for underlying cancer predisposition syndromes (CPS).

• Publication year

  2018

• Venue

  Pediatric Blood & Cancer

• Publication date

  2018-08-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pbc.27390PMID 30117275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The landscape of genomic alterations across childhood cancers

  2018cited by this paper
• Consequences of diagnosing a tumor predisposition syndrome in children with cancer: A literature review

  2018cited by this paper
• Incidental neuroblastoma with bilateral retinoblastoma: what are the chances?

  2018cited by this paper
• Genetic susceptibility to neuroblastoma.

  2017cited by this paper
• Retinoblastoma and Neuroblastoma Predisposition and Surveillance

  2017cited by this paper
• The McGill Interactive Pediatric OncoGenetic Guidelines: An approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation

  2017cited by this paper
• Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA

  2017cited by this paper
• Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk

  2017cited by this paper
• Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations

  2016cited by this paper
• Germline Mutations in Predisposition Genes in Pediatric Cancer.

  2016cited by this paper
• Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.

  2016cited by this paper
• Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors

  2016cited by this paper
• (Epi)genotype–phenotype correlations in Beckwith–Wiedemann syndrome: a paradigm for genomic medicine

  2016cited by this paper
• Recommendations of the Scientific Committee of the Italian Beckwith-Wiedemann Syndrome Association on the diagnosis, management and follow-up of the syndrome.

  2016cited by this paper
• Neurofibromatosis type 1 and malignancy in childhood

  2016cited by this paper
• Neuroblastoma: paradigm for precision medicine.

  2015cited by this paper
• Occurrence of Neuroblastoma among TP53 p.R337H Carriers

  2015cited by this paper
• Germline Mutations in Predisposition Genes in Pediatric Cancer.

  2015cited by this paper
• Vascular Smooth Muscle Cell Stiffness and Adhesion to Collagen I Modified by Vasoactive Agonists

  2015cited by this paper
• Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes

  2015cited by this paper
• PHOX2B polyalanine repeat length is associated with sudden infant death syndrome and unclassified sudden infant death in the Dutch population

  2014cited by this paper
• A case of Rubinstein‐Taybi syndrome and congenital neuroblastoma

  2014cited by this paper
• Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK?

  2014cited by this paper
• Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD)

  2014cited by this paper
• Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.

  2013cited by this paper
• Noonan syndrome.

  2013cited by this paper
• Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype

  2013cited by this paper
• Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus

  2013cited by this paper
• SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations)

  2012cited by this paper
• ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome

  2011cited by this paper
• Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations

  2011cited by this paper
• Germline gain‐of‐function mutations of ALK disrupt central nervous system development

  2011cited by this paper
• Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height

  2011cited by this paper
• Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes

  2011cited by this paper
• Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30‐year‐old mystery

  2010cited by this paper
• An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management.

  2010cited by this paper
• Multiple synchronous tumors in a child with Fanconi anemia.

  2010cited by this paper
• Identification of ALK as a major familial neuroblastoma predisposition gene

  2008cited by this paper
• The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.

  2008cited by this paper
• Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation

  2008cited by this paper
• Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

  2008cited by this paper
• Noonan syndrome

  2007cited by this paper
• Noonan syndrome

  2007cited by this paper
• Fanconi Anemia: Fanconi anemia, breast and embryonal cancer risk revisited

  2007cited by this paper
• Bilateral adrenal neuroblastoma and nephroblastoma occurring synchronously in a child with Fanconi's anemia and VACTERL syndrome.

  2006cited by this paper
• Facial Phenotype in Children and Young Adults with PHOX2B–Determined Congenital Central Hypoventilation Syndrome: Quantitative Pattern of Dysmorphology

  2006cited by this paper
• LEOPARD syndrome: Clinical diagnosis in the first year of life

  2006cited by this paper
• HRAS mutation analysis in Costello syndrome: Genotype and phenotype correlation

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003

  2006cited by this paper
• Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations.

  2005cited by this paper
• Risk of tumorigenesis in overgrowth syndromes: A comprehensive review

  2005cited by this paper
• Clinical features of NSD1-positive Sotos syndrome

  2004cited by this paper
• Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature.

  2003cited by this paper
• Familial neuroblastoma: a complex heritable disease.

  2003cited by this paper
• Co-occurrence of neuroblastoma and nephroblastoma in an infant with Fanconi's anemia.

  2002cited by this paper
• GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.

  2001cited by this paper
• Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children

  2000cited by this paper
• Rubinstein-Taybi syndrome: a girl with a history of neuroblastoma and premature thelarche.

  1999cited by this paper
• Leopard syndrome.

  1999cited by this paper
• Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families.

  1996cited by this paper
• Noonan Syndrome

  1996cited by this paper
• Tumors in Rubinstein-Taybi syndrome.

  1995cited by this paper
• Constitutional 1p36 deletion in a child with neuroblastoma.

  1993cited by this paper
• Frequency of congenital nevi, nevi spili and café-au-lait spots and their relation to nevus count and skin complexion in 939 children.

  1990cited by this paper
• Constitutional translocation t(1;17)(p36;q12–21) in a patient with neuroblastoma

  1990cited by this paper
• Café-au-lait spots in schoolchildren.

  1982cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper

• Comparative Outcomes of Gross Total Resection vs. Subtotal Resection Plus Radiotherapy for Preventing Craniopharyngioma Recurrence: A Meta-Analysis of the Endoscopic Endonasal Approach

  2025cites this paper
• Neuroblastoma Predisposition and Surveillance-An Update from the 2023 AACR Childhood Cancer Predisposition Workshop.

  2024cites this paper
• Double Heterozygous Pathogenic Variants in TP53 and CHEK2 in Boy with Undifferentiated Embryonal Sarcoma of the Liver

  2024cites this paper
• Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers

  2024cites this paper
• Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach

  2024cites this paper
• Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes

  2023cites this paper
• Diagnostic Strategies and Algorithms for Investigating Cancer Predisposition Syndromes in Children Presenting with Malignancy

  2022cites this paper
• Landscape of germline cancer predisposition mutations testing and management in pediatrics: Implications for research and clinical care

  2022cites this paper
• Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors

  2021cites this paper
• Identifying Childhood Cancer Survivors at Increased Genetic Risk for Second Malignant Neoplasms: Use of a Novel Screening Tool.

  2021cites this paper
• Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.

  2021cites this paper
• DICER1 syndrome in a young adult with pituitary blastoma

  2021cites this paper
• Recognition of Cancer Predisposition Syndromes

  2021cites this paper
• A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era

  2021cites this paper
• Supplemental Online Content

  2021cites this paper
• Predisposition to cancer in children and adolescents.

  2021cites this paper
• Enhanced childhood diseases treatment using computational models: Systematic review of intelligent experiments heading to precision medicine

  2021cites this paper
• Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer

  2021cites this paper
• CLINICAL PRACTICE OF A GENETICS REFERRAL SELECTION TOOL IN PEDIATRIC CANCER PATIENTS.

  2021cites this paper
• Proportion of children with cancer that have an indication for genetic counseling and testing based on the cancer type irrespective of other features

  2021cites this paper
• Effective identification of cancer predisposition syndromes in children with cancer employing a questionnaire

  2021cites this paper
• Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

  2021cites this paper
• Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes

  2020influential citation
• Pediatric Somatic Tumor Sequencing Identifies Underlying Cancer Predisposition.

  2019cites this paper
• Tumor risk and surveillance for children with hereditary disorders affecting growth

  2019cites this paper
• Advances in neuroblastoma therapy

  2019cites this paper